Work

Treatment with Pegylated Interferon-Alfa-2A (PEG-IFN-α-2A; PEGASYS™) for Patients with Essential Thrombocythemia (ET) and Polycythemia Vera (PV).

Year: 2006

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v108.11.4884.4884

Authors: Alfonso Quintas-Cardama, Hagop Kantarjian, Francis Giles, Jorge Cortes, Mary Ann Richie, Gautam Borthakur, Srdan Verstovsek

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2564965553

FWCI: 0.154

Cites:

Cited by: 1

Related to: 10